“Data mining from the biopharma supply chain, which is known to be incredibly complex, and digitizing crucial raw material information continues to be a target in biopharma 4.0,” she tells GEN.

Perhaps the biggest lesson here, though, is that the specifics of data, information, the whole world of processing the one into the other – sure, they’re new. But they are examples of known ...